Skip to content
Clinical Trials – home

Praxis Ebertplatz

Verifiedinfo

Germany Ebertplatz 1, 50668 Cologne, Germany

  • 1 trial recruiting
  • HIV infection · COVID-19 · Chronic hepatitis B
  • Adults and children

About Specializations

Praxis Ebertplatz in Cologne, Germany specialises in clinical trials of conditions such as HIV infection, COVID-19, Chronic hepatitis B, Hepatitis B, and other specialisations. This site conducts important research.

Main research areas of the site

HIV-1 Treatment Innovations

The medical center is at the forefront of HIV-1 treatment research, focusing on innovative therapeutic strategies to enhance patient outcomes. The center's research is dedicated to evaluating the efficacy of novel treatment regimens, such as the combination of bictegravir and lenacapavir, in maintaining viral suppression in individuals who are already successfully treated.

  • Novel Antiretroviral Therapies
  • Virological Suppression Strategies
  • Patient-Centric Treatment Approaches

Through its pioneering research, the center contributes significantly to the development of more effective and patient-friendly treatment options, aiming to improve the quality of life for those living with HIV-1.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ebertplatz 150668 CologneGermany
Recruiting now
1 trial
Conditions studied
4
Partner status
Verified

More sites in CologneGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:IBUZATRELVIR
  • Sponsor:Pfizer Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cabotegravir
  • Sponsor:Viiv Healthcare UK Limited

HIV infection

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Gilead Sciences Inc.

Chronic hepatitis B+1

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bepirovirsen
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Viiv Healthcare UK Limited

COVID-19

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pamapimod
  • Sponsor:Kinarus AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.